Market

Six therapies have outgrown the IPM growth

Increasing drug recalls due to safety concerns are driving the need for robust pharmacovigilance systems, but India has not kept…

Shalini Gupta finds out more in an interview with Adefemi Adenuga, GlobalDatas Healthcare Analyst covering industry dynamics

PIL petitioners to submit suggestions in two weeks; ISCR expresses concerns on slowdown of trial approvals

Karnataka state regulators write to state govt; Maharashtra and Gujarat gears up for action

Receives a total cash consideration of Rs 1050 crores as a part of the transaction from Claris-Otsuka

Focuses on European market and setting up of a new R&D centre in Ahmedabad

Alleges that the real problem is infrastructure not availability of doctors

Zydus & IDRI will collaborate to conduct clinical development activities in India for visceral leishmaniasis (Kala-Azar)

P7435 is a novel DGAT1 inhibitor for treatment of lipid disorders and diabetes